4 hrs ago | Myrtle Beach Online
Amgen approves $5 billion stock buyback
Biotech drugmaker Amgen said Monday its board approved a new $5 billion stock buyback plan.
Nplate(R) Data From MDS Studies Presented at ASH
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate in adult patients with myelodysplastic syndromes .
McMillan: Tech talk, trades and an agriculture ETF
Filed under: Newsletters , Amgen Inc , ETF Investing , Commodities , Oil , Agriculture , Stocks to Buy "Nothing has changed to unseat this liquidity-driven rally," says options expert Larry McMillan .
Tired of Waiting, Teva Advances
Teva Pharmaceutical has decided it's not worth waiting for the U.S. government to establish a pathway for approval of generic versions of biologic drugs.
Suit alleges Medicare fraud by drug company
November 29, 2009 Posted: November 27, 2009, 9:58 PM CST Last updated: November 27, 2009, 10:00 PM CST The allegations in the lawsuit are shocking.
Los Angeles Business Journal Online -...
Amgen's Platelet Drug in Spotlight
Editor's Note: A version of this story appeared in the Business Journal's November 30 print edition.
Biovitrum expands Kineret licence to include orpan indications
The amended agreement gives Biovitrum exclusive rights to develop, manufacture, market and sell Kineret for these additional indications in rare diseases.
Charity fundraisers rush to meet Amgen deadline
With a week left to match a challenge from the Amgen Foundation, a fund drive paying for basic needs of Ventura County residents has raised more than $130,000. The money is being given to The Buck Starts Here, a campaign aimed at helping local residents survive in a time of double-digit unemployment.
PRIMECAP Management Top Holdings: AMGN, LLY, NVS, FDX, GOOG, MDT
Managers in money management firm PRIMECAP Management Company prefer to stay behind the scene, focusing on money management and letting the other people to do the marketing for them.
In his article " The Market's 10 Best Stocks ," my colleague Tim Hanson pointed out the benefits of searching for the next multibagger success stories among the smallest of companies.
ImmunoGen licenses anti-cancer technology to Amgen
Drugmaker ImmunoGen Inc said it licensed its technology to develop anti-cancer drugs to Amgen Inc for a $1 million upfront payment.
Second license deal with Amgen to bring ImmunoGen another $35M
Waltham biotechnology firm ImmunoGen Inc. has announced a second license granted to Amgen Inc.
ImmunoGen licenses technology to Amgen for $1M
ImmunoGen Inc. said Thursday that Amgen Inc. licensed rights to a second potential cancer-treatment from the company for $1 million upfront.
While the market has staged a nice comeback since the spring and the economy seems to be slowly righting itself, things are still rough out there.
Rule Breaker . As long as I live, I'll never forget the day I first heard those two words.
Calabases biotech entrepreneur credits Amgen experience
Keith Leonard, founder of Kythera Biopharmaceuticals Inc. in Calabasas, said his degrees in engineering, business and history helped him launch a biotechnology company, but the ultimate decision was determined by an emotional readiness and a broad work experience.
Over his 28 years, Burrill's clients have included Steve Jobs of Apple, Genentech, Amgen and Gilead Sciences.
Mixed Results For Amgen's Latest Vectibix Trial
Vectibix, a cancer drug made by Amgen , did not show statistically significant survival rates for patients in a study of its effectiveness against advanced colorectal cancer.
Amgen suit unveils industry 'overfilling' practices
A lawsuit launched against Amgen Inc. on Oct. 30 raises important questions about what is accepted practice when it comes to manufacturing and administering certain drugs and whether the company encouraged the fraudulent sale of free drugs to increase their use.
IA could write this article the usual way -- byA showing you how to turn your thousands into millionsA through investments in solid, well-known companies.
Also on Topix